The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
The Warburg effect then and now: From cancer to inflammatory diseases
Open accessAbstract
Inflammatory immune cells, when activated, display much the same metabolic profile as a glycolytic tumor cell. This involves a shift in metabolism away from oxidative phosphorylation towards aerobic glycolysis, a phenomenon known as the Warburg effect. The result of this change in macrophages is to rapidly provide ATP and metabolic intermediates for the biosynthesis of immune and inflammatory proteins. In addition, a rise in certain tricarboxylic acid cycle intermediates occurs notably in citrate for lipid biosynthesis, and succinate, which activates the transcription factor Hypoxia‐inducible factor. In this review we take a look at the emerging evidence for a role for the Warburg effect in the immune and inflammatory responses. The reprogramming of metabolic pathways in macrophages, dendritic cells, and T cells could have relevance in the pathogenesis of inflammatory and metabolic diseases and might provide novel therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Garedew, A., Henderson, S. O., & Moncada, S. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.27 · Cited by 127
RetractedRegulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Self-citationKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 1×
“Succinate elevation from the TCA cycle has a negative feedback effect on PHDs, hence stabilizing Hif-1a [19].”
BackgroundShi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Tlr signalling augments macrophage bactericidal activity through mitochondrial ros
West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., et al. (2011) · Science · doi:10.1126/science.1207861 · Cited by 1,429
Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation
Krawczyk, C. M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R. J., Cross, J. R., Jung, E., Thompson, C. B., Jones, R. G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-249540 · Cited by 1,246
Metabolism of Inflammation Limited by AMPK and Pseudo-Starvation
O'Neill, L. A. J., & Hardie, D. G. (2013) · Nature · doi:10.1038/nature11862 · Cited by 1,133
Self-citationIdentification of lysine succinylation as a new post-translational modification
Zhang, Z., Tan, M., Xie, Z., Dai, L., Chen, Y., & Zhao, Y. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.495 · Cited by 1,027
Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,025
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Yang, W., Zheng, Y., Xia, Y., Ji, H., Chen, X., Guo, F., Lyssiotis, C. A., Aldape, K., Cantley, L. C., & Lu, Z. (2012) · Nature Cell Biology · doi:10.1038/ncb2629 · Cited by 918
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Anastasiou, D., Yu, Y., Israelsen, W. J., Jiang, J.-K., Boxer, M. B., Hong, B. S., Tempel, W., Dimov, S., Shen, M., Jha, A., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1060 · Cited by 816
Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
Gao, X., Wang, H., Yang, J. J., Liu, X., & Liu, Z.-R. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.001 · Cited by 772
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Hawley, S. A., Fullerton, M. D., Ross, F. A., Schertzer, J. D., Chevtzoff, C., Walker, K. J., Peggie, M. W., Zibrova, D., Green, K. A., Mustard, K. J., et al. (2012) · Science · doi:10.1126/science.1215327 · Cited by 739
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Lee, H.-M., Kim, J.-J., Kim, H. J., Shong, M., Ku, B. J., & Jo, E.-K. (2013) · Diabetes · doi:10.2337/db12-0420 · Cited by 734
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle
Winder, W. W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M., & Holloszy, J. O. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.6.2219 · Cited by 709
Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
Vander Heiden, M. G., Locasale, J. W., Swanson, K. D., Sharfi, H., Heffron, G. J., Amador-Noguez, D., Christofk, H. R., Wagner, G., Rabinowitz, J. D., Asara, J. M., et al. (2010) · Science · doi:10.1126/science.1188015 · Cited by 635
Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112607 · Cited by 596
Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014769108 · Cited by 586
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity
Rubic, T., Lametschwandtner, G., Jost, S., Hinteregger, S., Kund, J., Carballido-Perrig, N., Schwärzler, C., Junt, T., Voshol, H., Meingassner, J. G., et al. (2008) · Nature Immunology · doi:10.1038/ni.1657 · Cited by 525
Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
Ben Sahra, I., Le Marchand-Brustel, Y., Tanti, J.-F., & Bost, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1186 · Cited by 493
The mitochondrial citrate carrier: a new player in inflammation
Infantino, V., Convertini, P., Cucci, L., Panaro, M. A., Di Noia, M. A., Calvello, R., Palmieri, F., & Iacobazzi, V. (2011) · Biochemical Journal · doi:10.1042/bj20111275 · Cited by 385
Michelakis, E. D., McMurtry, M. S., Wu, X.-C., Dyck, J. R. B., Moudgil, R., Hopkins, T. A., Lopaschuk, G. D., Puttagunta, L., Waite, R., & Archer, S. L. (2002) · Circulation · doi:10.1161/hc0202.101974 · Cited by 369
Hong, J., Zhang, Y., Lai, S., Lv, A., Su, Q., Dong, Y., Zhou, Z., Tang, W., Zhao, J., Cui, L., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0719 · Cited by 366
Nath, N., Khan, M., Paintlia, M. K., Hoda, M. N., & Giri, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803563 · Cited by 354
Lu, C.-W., Lin, S.-C., Chen, K.-F., Lai, Y.-Y., & Tsai, S.-J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803508200 · Cited by 331
Ojuka, E. O. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2004339 · Cited by 271
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Sutendra, G., & Michelakis, E. D. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00038 · Cited by 262
Bioenergetics and the problem of tumor growth.
Racker, E. (1972) · PubMed · Cited by 252
Pierotti, M. A., Berrino, F., Gariboldi, M., Melani, C., Mogavero, A., Negri, T., Pasanisi, P., & Pilotti, S. (2013) · Oncogene · doi:10.1038/onc.2012.181 · Cited by 250
Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells
Tamada, M., Suematsu, M., & Saya, H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0859 · Cited by 237
Sun, R. C., Fadia, M., Dahlstrom, J. E., Parish, C. R., Board, P. G., & Blackburn, A. C. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0435-9 · Cited by 226
Dichloroacetate induces apoptosis in endometrial cancer cells
Wong, J. Y. Y., Huggins, G. S., Debidda, M., Munshi, N. C., & De Vivo, I. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.038 · Cited by 219
Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase
Park, C. S., Bang, B.-R., Kwon, H.-S., Moon, K.-A., Kim, T.-B., Lee, K.-Y., Moon, H.-B., & Cho, Y. S. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.025 · Cited by 208
Luo, W., & Semenza, G. L. (2011) · Oncotarget · doi:10.18632/oncotarget.299 · Cited by 190
Cao, W., Yacoub, S., Shiverick, K. T., Namiki, K., Sakai, Y., Porvasnik, S., Urbanek, C., & Rosser, C. J. (2008) · The Prostate · doi:10.1002/pros.20788 · Cited by 181
Human FoxP3+CD4+ regulatory T cells: their knowns and unknowns
Miyara, M., & Sakaguchi, S. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.137 · Cited by 180
Induced and Natural Regulatory T Cells in the Development of Inflammatory Bowel Disease
Mayne, C. G., & Williams, C. B. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f5a3 · Cited by 178
Efficacy of Dichloroacetate as a Lactate-Lowering Drug
Stacpoole, P. W., Nagaraja, N. V., & Hutson, A. D. (2003) · Journal of Clinical Pharmacology · doi:10.1177/0091270003043007001 · Cited by 171
Inhibition of Inducible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase
Pilon, G., Dallaire, P., & Marette, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401390200 · Cited by 166
Circulating Succinate is Elevated in Rodent Models of Hypertension and Metabolic Disease<subtitle />
(2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.05.010 · Cited by 162
The role of hypoxia-inducible factors in cancer
Maynard, M. A., & Ohh, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7082-2 · Cited by 139
Selection of cancer cells with repressed mitochondria triggers colon cancer progression
Sánchez‐Aragó, M., Chamorro, M., & Cuezva, J. M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq012 · Cited by 134
Rotstein, O. D., Pruett, T. L., Fiegel, V. D., Nelson, R. D., & Simmons, R. L. (1985) · Infection and Immunity · doi:10.1128/iai.48.2.402-408.1985 · Cited by 120
Gou, S., Cui, P., Li, X., Shi, P., Liu, T., & Wang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063969 · Cited by 113
A critical role for citrate metabolism in LPS signalling
O'Neill, L. A. J. (2011) · Biochemical Journal · doi:10.1042/bj20111386 · Cited by 111
Self-citationOXYGEN AS A FACTOR IN PHOTOSYNTHESIS
Turner, J., & Brittain, E. (1962) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.1962.tb01607.x · Cited by 110
Iron, the Oxygen-Carrier of Respiration-Ferment
Warburg, O. H. (1925) · Science · doi:10.1126/science.61.1588.575 · Cited by 105
Darekar, S., Georgiou, K., Yurchenko, M., Yenamandra, S. P., Chachami, G., Simos, G., Klein, G., & Kashuba, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042072 · Cited by 96
Kurebayashi, Y., Nagai, S., Ikejiri, A., & Koyasu, S. (2013) · Genes to Cells · doi:10.1111/gtc.12039 · Cited by 93
Emerging Metabolic Targets in Cancer Therapy
Zhao, Y., Liu, H., Riker, A. I., Fodstad, Ø., LeDoux, S. P., Wilson, G. L., & Tan, M. (2010) · Frontiers in bioscience · doi:10.2741/3826 · Cited by 85
Dickens, F. (1940) · Nature · doi:10.1038/145512b0 · Cited by 84
Gao, X., Wang, H., Yang, J. J., Chen, J., Jie, J., Li, L., Zhang, Y., & Liu, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448753 · Cited by 71
Larbi, A., Zelba, H., Goldeck, D., & Pawelec, G. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0509304 · Cited by 58
Increased pyruvate dehydrogenase kinase activity in response to sepsis
Vary, T. C. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.5.e669 · Cited by 56
Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease
Ishikawa, D., Okazawa, A., Corridoni, D., Li, J., Wang, X. M., Guanzon, M., Xin, W., Arseneau, K. O., Pizarro, T. T., & Cominelli, F. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.67 · Cited by 50
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
Dandapani, M., & Hardie, D. G. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120351 · Cited by 48
Temsirolimus: a safety and efficacy review
Bukowski, R. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.713344 · Cited by 42
PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials
Vamecq, J., Colet, J., Eynde, J. J. V., Briand, G., Porchet, N., & Rocchi, S. (2012) · PPAR Research · doi:10.1155/2012/304760 · Cited by 32
Jiang, L., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/489511a · Cited by 29
Cited by
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Metabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
Kelly, B., & O'Neill, L. A. (2015) · Cell Research · doi:10.1038/cr.2015.68 · Cited by 1,876
Self-citationThe immune system’s role in sepsis progression, resolution, and long-term outcome
Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880
The kynurenine pathway: a finger in every pie
Savitz, J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0414-4 · Cited by 756
Metadata
- Authors
- Palsson‐McDermott, E. M., & O'Neill, L. A. J.
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 2013-09-20
- Volume
- 35
- Issue
- 11
- Pages
- 965-973
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W1571252195
- Cited by
- 537
- References
- 72
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.